FIELD: medicine; pharmacology.
SUBSTANCE: invention concerns a pharmaceutical composition for treatment of the arthritises, containing in the structure as the first active ingredient antagonist of P2X7-receptor, and as the second active ingredient celecocsib, either rofecocsib, or valdecocsib. The invention also concerns the method of obtaining of the specified composition, its application for treatment of arthritises, to the method of treatment of arthritises, a pharmaceutical product and a set for treatment of arthritises.
EFFECT: increased efficiency at treatment of arthritises.
13 cl, 6 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α | 2004 |
|
RU2350354C2 |
| DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2214997C2 |
| DERIVATIVES OF ADAMANTANE, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING, METHODS FOR TREATMENT OF RHEUMATIC ARTHRITIS AND LUNG CHRONIC OBSTRUCTIVE DISEASE | 2000 |
|
RU2272025C2 |
| DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 2000 |
|
RU2254333C2 |
| DERIVATIVES OF ADAMANTANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF ITS PREPARING AND METHOD OF EFFECT ON IMMUNE SUPPRESSION | 1998 |
|
RU2197477C2 |
| APPLICATION OF CRTH2 ANTAGONISTS IN THERAPY | 2004 |
|
RU2412934C2 |
| 8-CARBAMOYL-2-(2,3-DI-SUBSTITUTED PYRID-6-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AS APOPTOSIS-INDUCING AGENTS FOR CANCER TREATMENT | 2012 |
|
RU2625315C2 |
| QUINAZOLINE DERIVATIVES EFFECTIVE AS VANILOID ANTAGONISTS | 2005 |
|
RU2396261C2 |
| QUINAZOLINONE DERIVATIVES EFFECTIVE AS VANILLOID ANTAGONISTS | 2005 |
|
RU2449995C2 |
| AZAADAMANTANE DERIVATIVES AND METHODS FOR APPLYING | 2007 |
|
RU2450002C2 |
